Inovio Pharmaceuticals Inc vs Quantumscape Corp — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $76.09M), while Quantumscape Corp trades at $6.38 (market cap $3.81B). The key difference: Quantumscape Corp is far larger — about 50.1× Inovio Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| INO | QS | |
|---|---|---|
Market Cap | $76.09M | $3.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $18.44 |
52-Week Low | $0.66 | $4.89 |
Enterprise Value | $47.10M | $3.02B |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →